BIOMARKERS OF COLLAGEN FIBER ARCHITECTURE IN EPITHELIAL OVERIAN CANCER (EOC) PATIENTS
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Jan 30, 2025
app pub date -
Oct 19, 2023
filing date -
Oct 19, 2023
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present disclosure, in some embodiments, relates to a method for determining a prognosis. The method includes measuring a collagen fiber orientation disorder (CFOD) within a digitized pathology image of a pathology slide corresponding to a patient that has or that has had EOC. A plurality of CFOD features are generated using the measured CFOD. A machine learning model is operated upon the plurality of CFOD features to determine an EOC prognosis for the patient.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully